Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy (Q54247387)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 18, 1993

edit

Language	Label	Description	Also known as
English	Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy	scientific article published on February 18, 1993

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

title

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy (English)

1 reference

stated in

Crossref

DOI

10.1038/361650A0

reference URL

https://api.crossref.org/works/10.1038/361650A0

retrieved

12 August 2024

main subject

multiple drug resistance

1 reference

based on heuristic

inferred from title

evolution

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

corrigendum / erratum

Erratum: Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

0 references

author

Joseph J Eron

series ordinal

5

object named as

Eron JJ

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

author name string

Y. K. Chow

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

M. S. Hirsch

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

D. P. Merrill

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

L. J. Bechtel

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

J. C. Kaplan

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

R. T. D'Aquila

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7679778

retrieved

12 August 2024

language of work or name

English

0 references

publication date

1 February 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

18 February 1993

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

7679778

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7679778

retrieved

12 August 2024

full work available at URL

http://www.nature.com/articles/361650a0

1 reference

stated in

Crossref

DOI

10.1038/361650A0

reference URL

https://api.crossref.org/works/10.1038/361650A0

retrieved

12 August 2024

http://www.nature.com/articles/361650a0.pdf

file format

PDF

1 reference

stated in

Crossref

DOI

10.1038/361650A0

reference URL

https://api.crossref.org/works/10.1038/361650A0

retrieved

12 August 2024

published in

Nature

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

volume

361

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

issue

6413

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

page(s)

650-654

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

cites work

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

General aspects of virus drug resistance with special reference to herpes simplex virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Retroviral Recombination and Reverse Transcription

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete nucleotide sequences of functional clones of the AIDS virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA sequencing with chain-terminating inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2F361650A0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1038/361650A0

reference URL

https://api.crossref.org/works/10.1038/361650A0

retrieved

12 August 2024

Identifiers

DOI

10.1038/361650A0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

Dimensions Publication ID

1031922245

0 references

PubMed publication ID

7679778

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7679778

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/7679778

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54247387&oldid=2226755787"